Comments on: Challenges for orphan medicines entering the European market – Part 3: Economic evidence development https://mtechaccess.co.uk/challenges-orphan-medicines-europe-economic-evidence/ Global market access & digital communication agency Wed, 04 Dec 2024 10:23:50 +0000 hourly 1 https://wordpress.org/?v=6.8.3 By: Operational challenges facing orphan medicines launching in Europe - market access for rare disease treatments https://mtechaccess.co.uk/challenges-orphan-medicines-europe-economic-evidence/#comment-84 Thu, 18 Feb 2021 11:24:02 +0000 https://mtechaccess.co.uk/?p=7264#comment-84 […] Read Part 1: Disease knowledge and awareness Read Part 2: Clinical evidence development Read Part 3: Economic evidence development […]

]]> By: Challenges for orphan medicines entering the European market - Part 1 https://mtechaccess.co.uk/challenges-orphan-medicines-europe-economic-evidence/#comment-80 Thu, 11 Feb 2021 12:22:43 +0000 https://mtechaccess.co.uk/?p=7264#comment-80 […] Read Part 2: Clinical evidence development Read Part 3: Economic evidence development […]

]]> By: Clinical evidence development: rare disease market access in Europe https://mtechaccess.co.uk/challenges-orphan-medicines-europe-economic-evidence/#comment-79 Thu, 11 Feb 2021 12:20:47 +0000 https://mtechaccess.co.uk/?p=7264#comment-79 […] Read Part 1: Disease knowledge and awareness Read Part 3: Economic evidence development […]

]]>